Epidemiological studies have shown that COPD is an independent risk factor for lung cancer56,57, and the use of ACE inhibitors or ARBs reduces the risks of COPD58 and lung cancer59. This evidence concerns the gene ACE and chronic obstructive pulmonary disease.